Amphastar Pharmaceuticals (AMPH) EBIT Margin (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) recorded EBIT Margin of 21.60% in Q2 2026, down 2.58 percentage points from 24.19% a year earlier but up 13.64 percentage points from the prior quarter.
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) EBIT Margin (2013 - 2026) Analysis & Trends
On a TTM basis, Amphastar Pharmaceuticals' EBIT Margin came in at 15.66% as of Jun 30, 2026, down 9.48 percentage points year-over-year; for FY2025, it came in at 19.50%, down 8.56 percentage points from FY2024.
- Annual EBIT Margin has a five-year change of +16.37 percentage points (FY2020 to FY2025).
- Across earlier years, EBIT Margin came in at 28.06% in FY2024 (-2.51 pp), 30.57% in FY2023 (+9.03 pp), 21.54% in FY2022 (+5.58 pp) and 15.96% in FY2021 (+12.83 pp).
- Quarterly EBIT Margin has ranged from 7.96% in Q1 2026 to 40.25% in Q3 2023 over the past five years.
- On a year-over-year basis, EBIT Margin has declined for eight consecutive quarters, with an average year-over-year change of -8.32 percentage points over the last eight quarters.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 20.92 percentage points in Q3 2023, against a drop of 16.64 percentage points in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 7.96% (Q1 2026), 19.45% (Q4 2025) and 13.20% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Amphastar Pharmaceuticals | 1.16 Bn | 23.86 Mn | 93.47 Mn | 21.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.60% |
| Mar 31, 2026 | 7.96% |
| Dec 31, 2025 | 19.45% |
| Sep 30, 2025 | 13.20% |
| Jun 30, 2025 | 24.19% |
| Mar 31, 2025 | 21.87% |
| Dec 31, 2024 | 24.20% |
| Sep 30, 2024 | 29.83% |
| Jun 30, 2024 | 30.27% |
| Mar 31, 2024 | 27.94% |
| Dec 31, 2023 | 30.31% |
| Sep 30, 2023 | 40.25% |
| Jun 30, 2023 | 25.32% |
| Mar 31, 2023 | 23.88% |
| Dec 31, 2022 | 28.02% |
| Sep 30, 2022 | 19.34% |
| Jun 30, 2022 | 20.10% |
| Mar 31, 2022 | 17.96% |
| Dec 31, 2021 | 20.06% |
| Sep 30, 2021 | 22.08% |
API Access
Amphastar Pharmaceuticals EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=AMPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "AMPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=AMPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();